Vaccine Name

 Havrix 720 

 Pharmaceutical　company

 UK GSK

 Suitable for 

     Injection for children over 1 year old
     Occasionally or frequently travel to Southeast Asia
     Infants who have started eating high-risk foods

 Effective Prevention

The inactivated hepatitis A virus is the major component of the hepatitis A vaccination. After being injected into the human body, the vaccine stimulates the development of antibodies, resulting in protection to the hepatitis A virus.

 Vaccination period

Two injections are required, separated by six months, and the validity term is approximately ten years.

 Side effect

     The most common side effects are moderate and include injection site soreness or swelling, headache, weariness, or lack of appetite.
     Severe allergic responses are uncommon. Even individuals who already have antibodies will not be harmed by the injection, and their negative effects will not be exacerbated.
     Injections can be given to people who have impaired immune systems or liver illness.

 Not suitable for

     People with fever
     People who have previously had an adverse reaction to any of the vaccine's ingredients

 Precautions

     It is advised that children receive their first and second doses of hepatitis A vaccine at the ages of 1 and 1.5.
     It normally takes a month after the first dose of the vaccination for the body to produce enough antibodies to protect against the hepatitis A virus.

  **When Vaqta is in short supply, the corporation has the option of substituting a vaccine of comparable quality - AVAXIM (Sanofi, France).